Your browser doesn't support javascript.
loading
Hymecromone: a clinical prescription hyaluronan inhibitor for efficiently blocking COVID-19 progression.
Yang, Shuai; Ling, Yun; Zhao, Fang; Li, Wei; Song, Zhigang; Wang, Lu; Li, Qiuting; Liu, Mengxing; Tong, Ying; Chen, Lu; Ru, Daoping; Zhang, Tongsheng; Zhou, Kaicheng; Zhang, Baolong; Xu, Peng; Yang, Zhicong; Li, Wenxuan; Song, Yuanlin; Xu, Jianqing; Zhu, Tongyu; Shan, Fei; Yu, Wenqiang; Lu, Hongzhou.
Afiliación
  • Yang S; Laboratory of RNA Epigenetics, Institutes of Biomedical Sciences & Shanghai Public Health Clinical Center & Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute Shanghai Medical College, Fudan University, Shanghai, P. R. China.
  • Ling Y; Shanghai Public Health Clinical Center, Fudan University, Shanghai, P. R. China.
  • Zhao F; Department of Radiology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, P. R. China.
  • Li W; Laboratory of RNA Epigenetics, Institutes of Biomedical Sciences & Shanghai Public Health Clinical Center & Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute Shanghai Medical College, Fudan University, Shanghai, P. R. China.
  • Song Z; Shanghai Public Health Clinical Center, Fudan University, Shanghai, P. R. China.
  • Wang L; Zhongshan Hospital, Fudan University, Shanghai, P. R. China.
  • Li Q; Laboratory of RNA Epigenetics, Institutes of Biomedical Sciences & Shanghai Public Health Clinical Center & Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute Shanghai Medical College, Fudan University, Shanghai, P. R. China.
  • Liu M; Laboratory of RNA Epigenetics, Institutes of Biomedical Sciences & Shanghai Public Health Clinical Center & Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute Shanghai Medical College, Fudan University, Shanghai, P. R. China.
  • Tong Y; Laboratory of RNA Epigenetics, Institutes of Biomedical Sciences & Shanghai Public Health Clinical Center & Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute Shanghai Medical College, Fudan University, Shanghai, P. R. China.
  • Chen L; Laboratory of RNA Epigenetics, Institutes of Biomedical Sciences & Shanghai Public Health Clinical Center & Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute Shanghai Medical College, Fudan University, Shanghai, P. R. China.
  • Ru D; Laboratory of RNA Epigenetics, Institutes of Biomedical Sciences & Shanghai Public Health Clinical Center & Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute Shanghai Medical College, Fudan University, Shanghai, P. R. China.
  • Zhang T; Laboratory of RNA Epigenetics, Institutes of Biomedical Sciences & Shanghai Public Health Clinical Center & Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute Shanghai Medical College, Fudan University, Shanghai, P. R. China.
  • Zhou K; Laboratory of RNA Epigenetics, Institutes of Biomedical Sciences & Shanghai Public Health Clinical Center & Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute Shanghai Medical College, Fudan University, Shanghai, P. R. China.
  • Zhang B; Laboratory of RNA Epigenetics, Institutes of Biomedical Sciences & Shanghai Public Health Clinical Center & Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute Shanghai Medical College, Fudan University, Shanghai, P. R. China.
  • Xu P; Laboratory of RNA Epigenetics, Institutes of Biomedical Sciences & Shanghai Public Health Clinical Center & Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute Shanghai Medical College, Fudan University, Shanghai, P. R. China.
  • Yang Z; Laboratory of RNA Epigenetics, Institutes of Biomedical Sciences & Shanghai Public Health Clinical Center & Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute Shanghai Medical College, Fudan University, Shanghai, P. R. China.
  • Li W; Laboratory of RNA Epigenetics, Institutes of Biomedical Sciences & Shanghai Public Health Clinical Center & Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute Shanghai Medical College, Fudan University, Shanghai, P. R. China.
  • Song Y; Zhongshan Hospital, Fudan University, Shanghai, P. R. China.
  • Xu J; Shanghai Public Health Clinical Center, Fudan University, Shanghai, P. R. China.
  • Zhu T; Zhongshan Hospital, Fudan University, Shanghai, P. R. China.
  • Shan F; Department of Radiology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, P. R. China. shanfei@shphc.org.cn.
  • Yu W; Laboratory of RNA Epigenetics, Institutes of Biomedical Sciences & Shanghai Public Health Clinical Center & Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute Shanghai Medical College, Fudan University, Shanghai, P. R. China. wenqiangyu@fudan.edu.cn.
  • Lu H; Shanghai Public Health Clinical Center, Fudan University, Shanghai, P. R. China. luhongzhou@fudan.edu.cn.
Signal Transduct Target Ther ; 7(1): 91, 2022 03 18.
Article en En | MEDLINE | ID: mdl-35304437
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 / Ácido Hialurónico Límite: Animals / Humans Idioma: En Revista: Signal Transduct Target Ther Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 / Ácido Hialurónico Límite: Animals / Humans Idioma: En Revista: Signal Transduct Target Ther Año: 2022 Tipo del documento: Article